The nasal mucociliary clearance: relevance to nasal drug delivery.
about
Nasal Absorption of Macromolecules from Powder Formulations and Effects of Sodium Carboxymethyl Cellulose on Their AbsorptionDelivering non-hormonal contraceptives to men: advances and obstacles.Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats.Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?In vivo colonization profile study of Bordetella bronchiseptica in the nasal cavity.Nasal delivery of antimigraine drugs: clinical rationale and evidence base.Endoscopic evaluation of therapeutic effects of "Anuloma-Viloma Pranayama" in Pratishyaya w.s.r. to mucociliary clearance mechanism and Bernoulli's principle.Nasal route: an alternative approach for antiemetic drug delivery.Strategies for enhanced peptide and protein delivery.Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.Nasal-nanotechnology: revolution for efficient therapeutics delivery.Current understanding of nasal morphology and physiology as a drug delivery target.Effects of ophthalmologic solutions on sinonasal ciliated epithelium.Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations.In vivo evaluation of dosage forms: application of gamma scintigraphy to non-enteral routes of administration.Intranasal Midazolam versus Rectal Diazepam for the Management of Canine Status Epilepticus: A Multicenter Randomized Parallel-Group Clinical Trial.In situ Gel of Metoprolol Tartrate: Physicochemical Characterization, In vitro Diffusion and Histological Studies.Nasal drug delivery in traditional persian medicine.Linking Suspension Nasal Spray Drug Deposition Patterns to Pharmacokinetic Profiles: A Proof-of-Concept Study Using Computational Fluid Dynamics.A new minimal-stress freely-moving rat model for preclinical studies on intranasal administration of CNS drugs.Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1.Absorption and Clearance of Pharmaceutical Aerosols in the Human Nose: Effects of Nasal Spray Suspension Particle Size and Properties.The therapeutic potential of monoclonal antibodies against respiratory syncytial virus.Ciliary beat frequency at six levels of the respiratory tract in cow, dog, guinea-pig, pig, rabbit and rat.Air-liquid interface culture of serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies.Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia.Intranasal co-delivery with the mouse zona pellucida 3 and GM-CSF expressing constructs enhances humoral immune responses and contraception in mice.The influence of AT1002 on the nasal absorption of molecular weight markers and therapeutic agents when co-administered with bioadhesive polymers and an AT1002 antagonist, AT1001.Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting.Intra Nasal In situ Gelling System of Lamotrigine Using Ion Activated Mucoadhesive Polymer.Intravail: highly effective intranasal delivery of peptide and protein drugs.In vivo evaluation of alginate microspheres of carvedilol for nasal deliveryEffect of Delivery Devices on Nasal Deposition and Mucociliary Clearance in Rhesus Monkeys
P2860
Q28553915-D4285069-9065-4F60-97B9-0AC253FF5297Q33674046-D2FBC21A-32BD-4090-817B-E4451757C91BQ34148017-FE71E6B5-3628-415C-9216-3CA1879F491BQ34383339-D4FA4D6A-24CD-45BA-BDBC-2C6DEFBE2A90Q36237914-71C6948B-C439-45F4-BFD5-0B3B91E887C7Q36641573-E8B2EAD8-6229-4342-9439-7915D0518ED2Q37670624-7DCEBD64-CD0C-43DD-9EA4-07318E63AD70Q37946545-35833292-63F1-4726-A354-65F7ADE4F409Q38104408-92A9DCE5-105C-4879-B6D3-404BF5250D18Q38195730-92784C0D-D7E3-4783-9C78-35B3EF2D39B2Q38217878-816092ED-263B-4FE8-AFCD-93FBCBC3C3B0Q38383290-06C90535-480A-49E7-AB96-96FB60F48D8DQ38763797-C94B6B61-8A9E-4C44-A97C-1C8F577833CEQ39459390-C54295EA-D75D-4338-97E1-FE1D57F4A4FEQ40594949-EC1847F7-5EAD-4239-A3F2-4DFD7109722FQ41001770-1286C241-DB4E-40C2-9861-8CB2F8414601Q41862627-C58E2A37-AFE4-47EC-99CD-F3AA137B210AQ41973041-333641BC-DD1F-4BF4-8771-F6D592ECE517Q42572439-EE8DBBE8-305D-42CE-B247-7FC2B74F14E0Q43101316-23C01869-6785-42ED-AE67-D0C4AF906BE2Q44682289-941BB975-9A13-43FA-B415-6F5202C3918EQ45023809-CF1D5806-787F-4C18-9E8B-89E87D3F051EQ45439981-451436D5-067A-4B06-A668-39C6B5867FD4Q46221503-4A178308-CFDA-44B4-8B8B-1163D26192D6Q46724241-F64C4416-C36C-46A3-9077-E1F8E6E32A9FQ47109628-C9BEB6A8-B030-4862-8241-6852E1D731A7Q47219257-EBF84C5F-717F-4627-A19E-03A4747ABAA5Q47339518-18958E72-A361-4C94-AFC0-EEBFD52BCCD2Q47893114-C49A374F-A2C3-44E0-93F2-D9C4384E5B9AQ49334799-092ED80D-E3FD-4731-BEFB-53F70C040FFDQ51168180-3A7D3F54-402D-409F-A977-0A810B81FE55Q57646926-8E29F8E6-EA89-4D2B-8604-CCA3CF0289E6Q58297693-C7068165-AEB0-47BB-B47E-272DF6DE4048
P2860
The nasal mucociliary clearance: relevance to nasal drug delivery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The nasal mucociliary clearance: relevance to nasal drug delivery.
@en
The nasal mucociliary clearance: relevance to nasal drug delivery.
@nl
type
label
The nasal mucociliary clearance: relevance to nasal drug delivery.
@en
The nasal mucociliary clearance: relevance to nasal drug delivery.
@nl
prefLabel
The nasal mucociliary clearance: relevance to nasal drug delivery.
@en
The nasal mucociliary clearance: relevance to nasal drug delivery.
@nl
P2093
P356
P1476
The nasal mucociliary clearance: relevance to nasal drug delivery.
@en
P2093
F W Merkus
J C Verhoef
N G Schipper
P304
P356
10.1023/A:1015830907632
P577
1991-07-01T00:00:00Z